CDK14 and hepatocellular carcinoma: Comparative data about the role of CDK14 in cancer is sparse, but authors relate that the over-expression of CDK14 promotes Wnt signaling [37], predicts chemotherapeutic resistance [26], and increases hepatocellular carcinoma motility [27].